Post Today follows the progress of CAR-T cell research, Chulalongkorn doctors recently prepare to open treatment for B-cell lymphoma patients after the research has been successful. Treat patients who have a 1% chance of survival within 1 year and continue to live. Revealing hope for health insurance rights as well as bone marrow transplantation